The NSF-funded Integrative Graduate Education and Research Traineeship (IGERT) program in Stem Cell Biomanufacturing was awarded to Georgia Tech in 2010 to educate and train the first generation of Ph.D. students in the translation and commercialization of stem cell technologies for diagnostic and therapeutic applications. The current state of the field of stem cell research offers a unique opportunity for engineers to contribute significantly to the generation of robust, reproducible and scalable methods for phenotypic characterization, propagation, differentiation and bioprocessing of stem cells.
A scientist at the Georgia Institute of Technology is piloting a new national initiative to make the U.S. the world leader in biomanufacturing of cell therapies.
The 10 graduate students are discussing stem cell population analysis, when it’s time. Before they can continue the discussion, Todd McDevitt, the instructor, has to do one thing — turn on the TV.
A separation technique based on adhesive force differences could advance stem cell therapies.